6y43
From Proteopedia
(Difference between revisions)
m (Protected "6y43" [edit=sysop:move=sysop]) |
|||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==Fibrinogen-like globe domain of human ANGPTL6== | |
- | + | <StructureSection load='6y43' size='340' side='right'caption='[[6y43]], [[Resolution|resolution]] 1.60Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[6y43]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6Y43 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6Y43 FirstGlance]. <br> | |
- | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=EPE:4-(2-HYDROXYETHYL)-1-PIPERAZINE+ETHANESULFONIC+ACID'>EPE</scene></td></tr> | |
- | [[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6y43 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6y43 OCA], [http://pdbe.org/6y43 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6y43 RCSB], [http://www.ebi.ac.uk/pdbsum/6y43 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6y43 ProSAT]</span></td></tr> |
- | [[ | + | </table> |
- | [[Category: | + | == Disease == |
- | [[Category: Arrowsmith, C | + | [[http://www.uniprot.org/uniprot/ANGL6_HUMAN ANGL6_HUMAN]] Familial cerebral saccular aneurysm. |
- | [[Category: | + | == Function == |
- | [[Category: | + | [[http://www.uniprot.org/uniprot/ANGL6_HUMAN ANGL6_HUMAN]] May play a role in the wound healing process. May promote epidermal proliferation, remodeling and regeneration. May promote the chemotactic activity of endothelial cells and induce neovascularization. May counteract high-fat diet-induced obesity and related insulin resistance through increased energy expenditure. |
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Arrowsmith, C H]] | ||
+ | [[Category: Bountra, C]] | ||
+ | [[Category: Coker, J A]] | ||
[[Category: Krojer, T]] | [[Category: Krojer, T]] | ||
- | [[Category: | + | [[Category: Marsden, B D]] |
- | [[Category: | + | [[Category: Midwood, K S]] |
- | [[Category: | + | [[Category: Mutisya, J M]] |
+ | [[Category: Structural genomic]] | ||
+ | [[Category: Yue, W W]] | ||
+ | [[Category: Damage-associated molecular pattern]] | ||
+ | [[Category: Immune system]] | ||
+ | [[Category: Sgc]] |
Revision as of 07:00, 4 March 2020
Fibrinogen-like globe domain of human ANGPTL6
|